针对COPD焦虑抑郁的定制心理干预(TANDEM):一项随机对照试验
TANDEM多中心随机对照试验评估基于认知行为方法的定制心理干预能否改善COPD伴焦虑和/或抑郁症状患者的焦虑或抑郁。干预组242例、对照组181例,由呼吸健康专业人员面对面实施6-8周。结果显示干预未改善6个月时HADS-A(均差-0.60,95%CI -1.40-0.21)和HADS-D(均差-0.66,95%CI -1.39-0.07),也未改善任何次要结局,且极不具成本效果。
要点
- 定制认知行为心理干预未改善COPD患者6个月时的焦虑或抑郁评分。
- 干预未改善任何次要结局,包括生活质量、社会参与和肺康复完成率。
- 干预组死亡13/242(5%)高于对照组3/181(2%),但均与干预无关。
核心结论
- 该认知行为干预由受训并督导的呼吸健康专业人员实施,不能改善晚期COPD伴抑郁或焦虑患者的心理共病。
研究设计与样本
- 多中心、实用性、随机对照试验,纳入COPD伴中重度气道阻塞且HADS-A和/或HADS-D提示轻中度焦虑和/或抑郁的患者。
- 按1.25:1随机分为干预组242例和对照组181例,干预由呼吸健康专业人员面对面实施6-8周。
主要发现
- 6个月时HADS-A均差-0.60(95%CI -1.40-0.21),HADS-D均差-0.66(95%CI -1.39-0.07),干预均未改善。
- 6个月和12个月时所有次要结局均未改善,包括BDI-II、BAI、SGRQ、社会参与、EQ-5D-5L、吸烟状态、肺康复完成和健康与社会照护资源使用。
- 干预组死亡13/242(5%),对照组死亡3/181(2%),但无死亡与干预相关。
- 健康经济分析发现该干预极不具成本效果。
临床怎么用
- 对于晚期COPD伴轻中度焦虑和/或抑郁的患者,不应常规采用该认知行为干预来改善心理共病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The TANDEM multicentre, pragmatic, randomised controlled trial evaluated whether a tailored psychological intervention based on a cognitive behavioural approach for people with COPD and symptoms of anxiety and/or depression improved anxiety or depression compared with usual care (control). METHODS: People with COPD and moderate to very severe airways obstruction and Hospital Anxiety and Depression Scale subscale scores indicating mild to moderate anxiety (HADS-A) and/or depression (HADS-D) were randomised 1.25:1 (242 intervention and 181 control). Respiratory health professionals delivered the intervention face-to-face over 6-8 weeks. Co-primary outcomes were HADS-A and HADS-D measured 6 months post-randomisation. Secondary outcomes at 6 and 12 months included: HADS-A and HADS-D (12 months), Beck Depression Inventory II, Beck Anxiety Inventory, St George's Respiratory Questionnaire, social engagement, the EuroQol instrument five-level version (EQ-5D-5L), smoking status, completion of pulmonary rehabilitation, and health and social care resource use. RESULTS: The intervention did not improve anxiety (HADS-A mean difference -0.60, 95% CI -1.40-0.21) or depression (HADS-D mean difference -0.66, 95% CI -1.39-0.07) at 6 months. The intervention did not improve any secondary outcomes at either time-point, nor did it influence completion of pulmonary rehabilitation or healthcare resource use. Deaths in the intervention arm (13/242; 5%) exceeded those in the control arm (3/181; 2%), but none were associated with the intervention. Health economic analysis found the intervention highly unlikely to be cost-effective. CONCLUSION: This trial has shown, beyond reasonable doubt, that this cognitive behavioural intervention delivered by trained and supervised respiratory health professionals does not improve psychological comorbidity in people with advanced COPD and depression or anxiety.
引用
- Taylor SJC, Sohanpal R, Steed L, et al. Tailored psychological intervention for anxiety or depression in COPD (TANDEM): a randomised controlled trial. Eur Respir J. 2023. PMID: 37620042. doi:10.1183/13993003.00432-2023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。